Serum Institute of India, Pune submitted safety, immunogenicity, and efficacy data generated on 23,745 participants aged more than or equal to 18 years or older from overseas clinical studies. The overall vaccine efficacy was found to be 70.42%: DCGI
Bharat Biotech has developed a Whole Virion Inactivated Corona Virus Vaccine (Covaxin) in collaboration with @ICMRDELHI and NIV (Pune). This vaccine is developed on Vero cell platform, which has a well-established track record of safety & efficacy in the country & globally: DCGI
M/s Cadila Healthcare Ltd., has developed a Novel Corona Virus-2019-nCov-Vaccine using DNA platform technology. The interim data suggests that the vaccine is safe and immunogenic with three doses when administered intradermally: DCGI
#MissionKarmayogi will be a shift from Rules-based to Roles-based HR management linking training with development of competencies of civil servants with a big focus on e-learning
This move will safeguard the interests of crores of Indian mobile and internet users. This decision is a targeted move to ensure safety and sovereignty of Indian cyberspace
As regards transgression of LAC, it was clearly stated that the violence in #GalwanValley on 15 June arose because Chinese side was seeking to erect structures just across the LAC and refused to desist from such actions
Prime Minister was clear that India would respond firmly to any attempts to transgress the LAC. In fact,he specifically emphasized that in contrast to the past neglect of such challenges, Indian forces now decisively counter any violations of LAC “unheroktehain, unhetoktehain”3/n